Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji

被引:13
|
作者
Wilson, N
Mansoor, O
Wenger, J
Martin, R
Zanardi, L
O'Leary, M
Rabukawaqa, V
机构
[1] Karori, Wellington, New Zealand
[2] WHO, Manila, Philippines
[3] WHO, CH-1211 Geneva, Switzerland
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
[5] WHO, Suva, Fiji
[6] Minist Hlth, Suva, Fiji
关键词
Haemophilus influenzae; rapid assessment tool; Pacific;
D O I
10.1016/S0264-410X(02)00825-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aims: To estimate Haemophilus influenzae type b (Hib) disease burden in Fiji in children under the age of 5 years (under-5s) prior to vaccine introduction. To compare estimates from WHO's Hib rapid assessment tool (RAT), with that from decline in disease after vaccine introduction. Methods: Laboratory data (meningitis), hospitalization and mortality data (pneumonia and meningitis) before and after Hib vaccine introduction were collected. The RAT protocol provides two independent estimates of pre-vaccine disease burden (one based on meningitis incidence laboratory data and the other based on mortality statistics). A third estimate uses the decline in disease following vaccine introduction. Results: The decline in meningitis hospitalizations implies a pre-vaccine Hib meningitis incidence of 66 per 100,000 in under-5s. This compares with a pre-vaccine RAT estimate of Hib meningitis incidence of 84 per 100,000 (for 1992-1993). The RAT estimated the total annual pre-vaccine Hib burden (meningitis plus pneumonia) at 476 cases and 36 deaths per year ("meningitis incidence method") and 70 cases and 5 deaths ("child mortality method"). Hib vaccine led to declines of 32% (95% confidence interval (CI) = 11-48%), and 78% (95% CI = 22-94%) for all under-5s meningitis hospitalizations and deaths, respectively. There was no similar consistent decline in pneumonia hospitalizations or deaths after vaccine introduction, except for a statistically significant reduction in pneumonia mortality in children aged under 1 year. Conclusions: Hib disease constitutes an important burden on the health of Pacific children that can be rapidly reduced with Hib vaccine. In this setting, routine morbidity statistics (comparing pre-and post-vaccine) provided an estimate of Hib meningitis burden which is broadly similar to that of the Hib RAT, suggesting that both might be valid ways to estimate Hib meningitis incidence. However, Hib pneumonia burden could not be estimated from routine statistics. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1907 / 1912
页数:6
相关论文
共 50 条
  • [1] Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease
    Gilsdorf, Janet R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 224 : S321 - S330
  • [2] DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA
    ADAMS, WG
    DEAVER, KA
    COCHI, SL
    PLIKAYTIS, BD
    ZELL, ER
    BROOME, CV
    WENGER, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02): : 221 - 226
  • [3] Haemophilus influenzae type B (HiB) is back
    Hanousek, J
    Swart, M
    [J]. ANAESTHESIA, 2003, 58 (08) : 813 - 814
  • [4] Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa
    von Gottberg, A.
    de Gouveia, L.
    Madhi, S. A.
    du Plessis, M.
    Quan, V.
    Soma, K.
    Huebner, R.
    Flannery, B.
    Schuchat, A.
    Klugman, K. P.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (10) : 811 - 818
  • [5] THE INTRODUCTION OF HAEMOPHILUS-INFLUENZAE-B (HIB) VACCINE
    MURPHY, JFA
    [J]. IRISH MEDICAL JOURNAL, 1992, 85 (04) : 123 - 123
  • [6] Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era
    Nix, Eli B.
    Hawdon, Nicole
    Gravelle, Sean
    Biman, Birubi
    Brigden, Malcolm
    Malik, Saleem
    McCready, William
    Ferroni, Garry
    Ulanova, Marina
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (05) : 766 - 771
  • [7] Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine
    Howie, Stephen R. C.
    Antonio, Martin
    Akisanya, Abiodun
    Sambou, Sana
    Hakeem, Ishrat
    Secka, Ousman
    Adegbola, Richard A.
    [J]. VACCINE, 2007, 25 (34) : 6305 - 6309
  • [8] Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review
    Chongmelaxme, Bunchai
    Hammanee, Maythika
    Phooaphirak, Wariya
    Kotirum, Surachai
    Hutubessy, Raymond
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1094 - 1106
  • [9] Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease
    Ladhani, Shamez
    Neely, Fiona
    Heath, Paul T.
    Nazareth, Bernadette
    Roberts, Richard
    Slack, Mary P. E.
    McVernon, Jodie
    Ramsay, Mary E.
    [J]. JOURNAL OF INFECTION, 2009, 58 (01) : 3 - 14
  • [10] REDUCTION OF OROPHARYNGEAL CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) IN CHILDREN IMMUNIZED WITH AN HIB CONJUGATE VACCINE
    TAKALA, AK
    ESKOLA, J
    LEINONEN, M
    KAYHTY, H
    NISSINEN, A
    PEKKANEN, E
    MAKELA, PH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (05): : 982 - 986